Insider trades
Lumira Capital Investment Management, 10% Owner of enGene Therapeutics ENGN, has filed 0 purchases and 4 sales on the open market. The latest trade was on 24/02/20.
Lumira Capital Investment Management
10% Owner
- Company
- enGene Therapeutics ENGN
- First filing
- 23/01/11
- Trades
- 6 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- No record
- Last trade
- 24/02/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
EDSA | Open-market sale | 23/01/09–23/01/10 | 23/01/11 | 297,474 sh4 trades | $2.64avg. | $786,710.49 | −66.4% |
